VaLogic

VaLogic Valogic LLC

VaLogic , LLC has provided responsive, dedicated resources to deliver competitive advantage for clients of all sizes and stages of product development who are working at the forefront of life-enhancing therapeutics since 2001. With a whole system view, the company develops a customized, integrative approach that:
* Manages risk
* Reduces time to market, and
* Guarantees your

supply chain

Whether a client is building new facilities, implementing controls to drive compliance, or maintaining their routine operations, VaLogic is the single, smart choice for pragmatic consultation and reliable services to best position your business for success.

⚾ Summer Outing Home Runs for VaLogic! ⚾This month, our teams traded their hard hats and compliance reports for baseball...
08/31/2026

⚾ Summer Outing Home Runs for VaLogic! ⚾

This month, our teams traded their hard hats and compliance reports for baseball caps and peanuts as we hit the ballparks for our annual summer company outing!

Our Frederick, MD team cheered on the Frederick Keys at Nymeo Field at Harry Grove Stadium, while our Avon, MA office took in the electric atmosphere of a Boston Red Sox game at Fenway Park.

It was an incredible opportunity for both offices to step away from the lab and the drawing board to connect, unwind, and celebrate the team that makes VaLogic great. Whether it was rooting for a home run or just enjoying some classic ballpark snacks, the energy and camaraderie were off the charts.

A huge thank you to everyone who came out to make this summer outing a grand slam. Here's to many more team memories and continued success together!

A Certificate of Analysis (CoA) Is Not a Qualification.A certificate of analysis tells you what a supplier says about th...
08/27/2026

A Certificate of Analysis (CoA) Is Not a Qualification.

A certificate of analysis tells you what a supplier says about their material. It doesn’t tell you whether they can produce it consistently.

That is the difference between a document and a qualification.

A compliant supplier program includes a risk-based tier structure, a written quality agreement, and periodic performance reviews. Qualification is not something you complete once at onboarding and never revisit. It is something you maintain.

The most common gap is treating initial approval as permanent approval.

Are your current suppliers still qualified, or are they just on a list?

Our latest blog covers what supplier qualification actually requires under FDA and ICH Q10, and where most programs leave gaps that become inspection findings. https://hubs.li/Q04vcft80

Documents Can Be Prepared for an Audit. Systems Cannot.That’s the core principle behind an effective supplier audit prog...
08/25/2026

Documents Can Be Prepared for an Audit. Systems Cannot.

That’s the core principle behind an effective supplier audit program.

If your audit scope starts with a document checklist, you will leave with a document checklist. If it starts with the question "is this supplier's system capable of consistent performance," you will leave with something more useful.

Ask to see a recent CAPA. Read the investigation, not just the action items. A corrective action that closes with "retrain analyst" without explaining why the error occurred is not a root cause conclusion.

Strong audits find what matters. That is what they are designed to do.

Our latest blog covers how to scope, conduct, and document supplier audits that actually evaluate quality system capability. https://hubs.li/Q04v06tR0

Your Audit Trail Is Only as Strong as the Culture Behind ItMost lab data integrity problems do not start with bad intent...
07/29/2026

Your Audit Trail Is Only as Strong as the Culture Behind It

Most lab data integrity problems do not start with bad intentions.

They start with unclear procedures, shared logins, and audit trails that no one reviews.

ALCOA+ sets the standard: Attributable. Legible. Contemporaneous. Original. Accurate. Complete. Consistent. Enduring. Available.

Every one of those words is enforceable.

The labs that stay compliant are not just following a checklist. They have built a culture where accurate documentation is the default, not the exception.

Are your analysts trained on why each step matters, not just how to do it?

Our latest blog breaks down what ALCOA+ actually requires in a working lab environment, including the failure points that show up most often during inspections. https://hubs.li/Q04r45840

Managing every supplier with the same intensity is not thorough. It is a resource problem that leaves your highest-risk ...
07/27/2026

Managing every supplier with the same intensity is not thorough. It is a resource problem that leaves your highest-risk relationships under-monitored.

A risk-based supplier tiering model is not a way to do less. It is a way to concentrate audit frequency, qualification depth, and ongoing monitoring where patient safety and regulatory exposure are highest.

The differentiating factor is not spend or relationship length. It is impact: what happens to product quality and patient safety if this supplier fails?

Suppliers providing active pharmaceutical ingredients, primary packaging components, or materials with direct product contact sit at the top of the risk profile. They require on-site qualification audits, formal annual performance reviews, and incoming material verification.

Indirect material suppliers, consumables, and commodities with no product contact sit at the lower end. Documented questionnaire qualification and periodic CoA review are proportionate and defensible.

The tiering criteria must be defined in your supplier management SOP and applied consistently at every new supplier evaluation. Tiering decisions made informally, or applied inconsistently across categories, are themselves a finding.

Regulators do not require that you audit every supplier equally. They require that you know which ones matter most, and that your program reflects that knowledge.

Where does the most unmanaged supplier risk sit in your supply chain?

Out-of-specification. Out-of-trend. Two different signals. Two different responses.OOS (Out-of-Specification) A result f...
07/22/2026

Out-of-specification. Out-of-trend. Two different signals. Two different responses.

OOS (Out-of-Specification) A result falls outside the established acceptance criteria defined in the specification. This triggers a mandatory, documented two-phase investigation under 21 CFR 211.192. The batch cannot be released until the investigation is complete and a disposition decision is made.

OOT (Out-of-Trend) A result is within specification but deviating from the expected statistical pattern over time. No regulatory mandate requires a specific investigation format but ignoring OOT results is how OOS results arrive without warning.

The practical distinction: OOS results are a compliance event. OOT results are an early warning system.

Organizations that only respond to OOS findings are managing compliance reactively. Organizations that track OOT data are managing quality proactively.

The FDA expects both. Warning letters cite missing trending programs with the same regularity they cite inadequate OOS investigations.

Does your quality system treat OOT data as a leading indicator, or does it wait for a specification exceedance before generating a record?

VaLogic Bio is proud to spotlight LogiPoint®, our GMP-ready environmental and facility monitoring system built for the l...
07/15/2026

VaLogic Bio is proud to spotlight LogiPoint®, our GMP-ready environmental and facility monitoring system built for the life sciences, biotech, and pharmaceutical industries.

One unexpected excursion can derail everything. A freezer warms by a few degrees. Pressure drops in a cleanroom. Humidity spikes in an incubator. A single event can compromise patient safety, put millions in product at risk, and leave your team scrambling during an FDA inspection.

LogiPoint® delivers more than just numbers on a screen:

✅ 24/7 real-time environmental monitoring across all critical systems
✅ 21 CFR Part 11 compliant: audit-ready reports at your fingertips
✅ Redundant safeguards that protect against network or power loss
✅ Remote access from anywhere: desktop, tablet, or smartphone
✅ Real-time alerts via text or email when conditions exceed limits

🔗 Learn more: https://hubs.li/Q04ptQLS0

MYTH: If a supplier provides a Certificate of Analysis with every shipment, your incoming material qualification is cove...
07/14/2026

MYTH: If a supplier provides a Certificate of Analysis with every shipment, your incoming material qualification is covered.

REALITY: A CoA documents a result. It does not document the conditions under which that result was generated.

A compliant supplier audit program goes beyond document review. The questions that matter:

1. Is the supplier's test method equivalent to yours — or are they testing against their own internal specification, which may differ from yours?
2. Is their analytical equipment calibrated and qualified? When was it last qualified?
3. Who performs the testing — a dedicated QC function or production staff wearing multiple hats?
4. How does the supplier handle an OOS result internally? What is their investigation and release process?
5. What change control process governs method changes, equipment changes, or raw material substitutions — and would you be notified?

A supplier who consistently provides clean CoAs but cannot answer these questions is not a qualified supplier. They are an unaudited risk.

What question do you ask in supplier audits that others rarely think to ask?

Follow VaLogic for GMP compliance insights.

We are excited to announce that VaLogic will be exhibiting at the 136th Florida Pharmacy Association Annual Meeting & Co...
07/14/2026

We are excited to announce that VaLogic will be exhibiting at the 136th Florida Pharmacy Association Annual Meeting & Convention from July 16 to 18, at the JW Marriott Orlando Bonnet Creek Resort & Spa! 🎉

At VaLogic, we address the compliance challenges faced by pharmacy leaders. With over 20 years of GMP experience, we offer integrated services for 503A and 503B compounding pharmacies, including cleanroom design, environmental monitoring, and SOP development. Our goal is to keep your pharmacy audit-ready, so you can focus on providing quality patient care.

Visit our booth to discover how we can alleviate your team's compliance burdens and meet our team.
✅ Bill Robertson - CEO
✅ Dawn Robertson - VP
✅ Matt Bernard - VP of Sales & Marketing
✅ Soma Penumajji Ph.D., MBA - VP of Operations

An Out-of-Specification Result Is Not Your Problem. A Weak Investigation Is.Here is what FDA's two-phase OOS structure a...
07/10/2026

An Out-of-Specification Result Is Not Your Problem. A Weak Investigation Is.

Here is what FDA's two-phase OOS structure actually requires:

PHASE 1: Laboratory Investigation Rule out analyst error, instrument problems, and sample prep issues before touching the product conclusion. Document everything in real time. No retroactive investigations.

PHASE 2: Full-Scale Investigation If Phase 1 finds no lab cause, expand to manufacturing. Review the batch record, raw materials, and process parameters. Reach an actual root cause conclusion.

"No assignable cause found" is not a conclusion. It is a signal that Phase 2 was not thorough enough. Most OOS failures are process failures. Build the investigation program before you need it.

Our latest blog walks through the two-phase OOS investigation structure FDA expects, where programs typically break down, and what a defensible investigation record actually looks like.

Read the Full Blog: https://hubs.li/Q04nJhCP0

Address

21 Byte Court
Frederick, MD
21702

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+12405291673

Website

Alerts

Be the first to know and let us send you an email when VaLogic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to VaLogic:

Shortcuts

Share

Category